How cannabinoids regulate immunity: promises and cautions

This comprehensive review examines how cannabinoids—the active compounds in marijuana—interact with the immune system and their potential therapeutic applications in treating immune-related diseases. The research synthesizes recent findings showing that cannabinoids can modulate immune function through the endocannabinoid system, offering promising possibilities for treating conditions where immune dysregulation plays a key role. However, the authors emphasize that while the therapeutic potential is significant, much research remains contradictory and mechanisms of action are still not fully understood.

The review highlights important safety considerations that users and researchers must understand. Cannabinoid exposure can affect fetal nervous system development, and common adverse effects include dizziness, nausea, and dry mouth. The authors note that despite decades of research, many conflicting results exist in the scientific literature, making it difficult to draw definitive conclusions about which immune conditions benefit most from cannabinoid treatment and at what doses.

Moving forward, this review underscores the need for rigorous clinical research to clarify cannabinoid mechanisms in immune health, establish safe dosing protocols, and identify which patient populations will benefit most from treatment. The gap between laboratory findings and clinical applications remains significant, and resolving contradictions in current research is essential before widespread medical recommendations can be made.